These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14704502)

  • 1. [Oxidative stress and endothelial dysfunction].
    Jarasūniene D; Simaitis A
    Medicina (Kaunas); 2003; 39(12):1151-7. PubMed ID: 14704502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice.
    Antoniades C; Tousoulis D; Tentolouris C; Toutouzas P; Stefanadis C
    Herz; 2003 Nov; 28(7):628-38. PubMed ID: 14689123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The main determinants of endothelial dysfunction].
    Garaliene V
    Medicina (Kaunas); 2006; 42(5):362-9. PubMed ID: 16778463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition.
    Neutel JM
    Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural antioxidant compounds in risk factors for CVD.
    Kaliora AC; Dedoussis GV
    Pharmacol Res; 2007 Aug; 56(2):99-109. PubMed ID: 17572098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is the supplementation with antioxidants effective in the treatment of atherosclerosis?].
    Schröder S
    Dtsch Med Wochenschr; 2004 Feb; 129(7):321-6. PubMed ID: 14765332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coronary artery disease in patients with diabetes mellitus and its treatment].
    Teramoto T
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():94-9. PubMed ID: 11989270
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypertension and arteriosclerosis].
    Sasamura H; Itoh H
    Nihon Rinsho; 2011 Jan; 69(1):125-30. PubMed ID: 21226272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NO and atherosclerosis].
    Ohtani K; Egashira K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():544-7. PubMed ID: 15506446
    [No Abstract]   [Full Text] [Related]  

  • 10. [Programmed cellular death and atherogenesis: from molecular mechanisms to clinical aspects].
    Lesauskaite V; Ivanoviene L; Valanciūte A
    Medicina (Kaunas); 2003; 39(6):529-34. PubMed ID: 12829874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should angiotensin II receptor blockers and statins be combined?
    Nickenig G
    Circulation; 2004 Aug; 110(8):1013-20. PubMed ID: 15326080
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypertension and endothelial dysfunction].
    Zoghi M; Nalbantgil I
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):142-7, AXVIII. PubMed ID: 12134540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology of mild hypertension: role of endothelial function].
    Matsuoka H; Imaizumi T
    Nihon Rinsho; 2008 Aug; 66(8):1517-24. PubMed ID: 18700551
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and endothelial dysfunction: a clinical perspective.
    Calles-Escandon J; Cipolla M
    Endocr Rev; 2001 Feb; 22(1):36-52. PubMed ID: 11159815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting endothelial dysfunction in hypertensive subjects.
    Thuillez C; Richard V
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function, arterial stiffness and lipid lowering drugs.
    Tziomalos K; Athyros VG; Karagiannis A; Mikhailidis DP
    Expert Opin Ther Targets; 2007 Sep; 11(9):1143-60. PubMed ID: 17845142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coronary atherosclerosis and vascular endothelial dysfunction].
    Nishinaga M
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():75-9. PubMed ID: 12734956
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vasoprotective effects of statins and angiotensin II blockers in atherothrombosis].
    Egido J; Ruiz-Ortega M; Muñoz-García B; Martín-Ventura JL; Blanco-Colio LM
    Nefrologia; 2005; 25 Suppl 2():117-28. PubMed ID: 16050414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors, endothelial cell turnover and lipid transport in atherogenesis.
    Lin SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):309-16. PubMed ID: 9037845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.